Table 4

The perioperative impact of anesthesia technique with or without peripheral nerve block use in total hip arthroplasty

ComplicationsPrimary analysisSubgroup analysis
Total OR (95% CI)NObservational OR (95% CI)NRCT OR (95% CI)N
Mortality6 48 0.61 (0.36 to 1.04)342 8260.61 (0.36 to 1.04)342 826
Cardiac without MI6 48 56 0.84 (0.76 to 0.93)*342 9410.84 (0.76 to 0.93)*342 8260.20 (0.01 to 4.18)115
Myocardial infarction56 61 1.00 (0.14 to 7.19)2771.00 (0.14 to 7.19)277
Pulmonary6 48 56 65–67 0.70 (0.60 to 0.81)*343 1980.71 (0.62 to 0.83)*342 8260.34 (0.16 to 0.73)*372
Respiratory failure48 65–67 0.36 (0.17 to 0.74)*3570.49 (0.04 to 5.58)1000.35 (0.16 to 0.75)*257
Pneumonia56 0.33 (0.01 to 8.35)1150.33 (0.01 to 8.35)115
Gastrointestinal6 56 0.55 (0.43 to 0.70)*342 8410.55 (0.43 to 0.70)*342 7260.50 (0.04 to 5.67)115
Renal6 48 0.67 (0.59 to 0.76)*342 8260.67 (0.59 to 0.76)342 826
Renal failure48 0.33 (0.01 to 8.21)1000.33 (0.01 to 8.21)*100
Delirium48 65 81–83 141 0.30 (0.17 to 0.53)*7231.53 (0.24 to 9.59)1000.25(0.14 to 0.46)*623
Stroke6 0.83 (0.53 to 1.29)342 7260.83 (0.53 to 1.29)342 726
Surgical site infection6 48 61 66 0.55 (0.47 to 0.64)*343 0910.55 (0.47 to 0.64)*342 8260.58 (0.08 to 4.47)265
Any infection6 56 0.71 (0.65 to 0.78)*342 8410.71 (0.65 to 0.78)*342 7260.33 (0.01 to 8.35)115
Sepsis48 66 0.32 (0.03 to 3.16)2030.33 (0.01 to 8.21)1000.32 (0.01 to 8.06)103
Thromboembolism6 66 103 142 0.74 (0.58 to 0.96)*342 9550.73 (0.57 to 0.95)*342 7261.73 (0.22 to 13.27)229
Perioperative nerve injury108 143 0.72 (0.38 to 1.35)11 1180.61 (0.30 to 1.26)11 118
Blood transfusion6 56 83 111 112 0.84 (0.83 to 0.86)*873 0790.84 (0.83 to 0.86)*872 8151.19 (0.66 to 2.16)264
Blood loss†142 66 67 83 114–118 10.61 (−4.28 to 25.50)45440.00 mL (−56.81 to 136.81)629.90 mL (−5.18 t o 24.97)392
Critical care admission6 90 0.91 (0.86 to 0.95)*342 8850.91 (0.86 to 0.95)*342 7260.29 (0.01 to 5.77)159
Length of stay†
90 144 56 103 118 121–123 145–147
−0.36 (−0.42 to −0.31)*872−0.12 days (−0.20 to −0.03)*205−0.55 days (−0.63 to −0.48)*667
  • Pulmonary: pulmonary complications excluding pneumonia.

  • CNS: central nervous system complications.

  • All infections: all infections including pneumonia and sepsis.

  • N (NA/GA): total number of patients with neuraxial/general anesthesia.

  • *P<0.05 .

  • †Continuous outcomes reported as mean difference.

  • MI, myocardial infarction; RCT, randomized controlled trial.